Judge OKs $54M Aggrenox Settlement In Pay-For-Delay Suit
A Connecticut federal judge has signed off on a $54 million settlement between indirect purchasers of stroke prevention medicine Aggrenox and drugmakers Teva Pharmaceutical and Boehringer Ingelheim to end allegations the companies blocked generic alternatives...To view the full article, register now.
Already a subscriber? Click here to view full article